Sterile bioreactor sampling system unveiled
A new method of preventing bioreactor contamination when sampling has been unveiled by UK firm Cellexus Biosystems.
Archives for November 6, 2006
Isogenica enters into a deal to discover peptide ligands
Isogenica has entered into a research and licence option agreement with UCB for the discovery of novel peptide ligands, which UCB intends to incorporate into therapeutic products.
IntegraGen announces €2m investment and partnership
IntegraGen has made significant waves in the area of personalised healthcare announcing a collaborative with the DSM Personalised Nutrition Group and a €2m equity investment by DSM Venturing.
Ground Zero Pharma expands regulatory consulting services
Ground Zero Pharmaceuticals (GZP) has announced an expansion to the services it offers enabling the expansion into more of its clients' late-stage development programs, with the potential for creating submissions that lead to FDA approval.
California waives ban on mercury flu shots to face shortage
California's Health and Human Services (HHS) has decided to temporarily suspend a ban on mercury-based flu vaccines given to children under three, citing a vaccine shortage caused by production delays.
Unusual protein distribution enhances CF knowledge
Scientists have discovered an unusual distribution of two proteins in the lungs and airways of people with cystic fibrosis could form the basis of a therapy that could better define the immune system's role in cystic fibrosis.
MSD invests €100m in Irish drug making arm
Merck Sharp & Dohme has just announced a €100m investment in South Tipperary, Ireland to build a new formulation R&D centre and drug manufacturing plant.